Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$122.14 /

+3.84 (+3.25%)

 06:27
05/18/22
 05/18
06:27
 05/18/22
06:27

JPMorgan investors reject Dimon's $50M bonus, WSJ reports

JPMorgan shareholders rejected a roughly $50M retention bonus for CEO Jamie Dimon as well as the bank's compensation plans, The Wall Street Journal's David Benoit reports. Just 31% of investors voted for the bank's pay plans at its annual meeting. The vote comes as the bank has faced criticism over its spending and investments, with both ISS and Glass Lewis recommending investors vote against the pay packages. Reference Link

  • 14

    Jul

OTHER BREAKING NEWS FROM THE FLY

Recommendations
AvalonBay price target lowered to $212 from $260 at Mizuho » 07:58
06/27/22
06/27
07:58
06/27/22
07:58
AVB

AvalonBay

$195.14 /

-1.415 (-0.72%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

06/03/22
AvalonBay says two-month Same Store Residential rental revenue up 13%
04/05/22
PS Business Parks names Stephen Wilson as CEO, effective immediately
03/04/22
AvalonBay reports QTD same store residential rental revenue up 7.3% y/y
01/18/22
PS Business Parks names Stephen Wilson interim CEO
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

06/24/22 Truist
AvalonBay price target lowered to $224 from $263 at Truist
06/22/22 Credit Suisse
AvalonBay initiated with a Neutral at Credit Suisse
05/19/22 Scotiabank
AvalonBay price target lowered to $238 from $262 at Scotiabank
05/10/22 Barclays
AvalonBay price target lowered to $229 from $263 at Barclays
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

04/27/22
AvalonBay sees FY22 core FFO $9.38-$9.78, consensus $9.55
04/27/22
AvalonBay sees Q2 core FFO $2.25-$2.37
04/27/22
AvalonBay reports Q1 core FFO $2.26, consensus $2.26
02/02/22
AvalonBay sees FY22 core FFO $9.30-$9.80, consensus $9.39
  • 07
    Apr
AVB AvalonBay
$195.14 /

-1.415 (-0.72%)

04/06/22
Fly Intel: After-Hours Movers
Recommendations
Apartment Income REIT price target lowered to $45 from $59 at Mizuho » 07:58
06/27/22
06/27
07:58
06/27/22
07:58
AIRC

Apartment Income REIT

$41.36 /

+0.02 (+0.05%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

06/23/22
Westwater Resources CFO Jeffrey Vigil to retire, Steven Cates to succeed
03/28/22
Apartment Income REIT CFO sells $766K in common stock
AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

06/24/22 Truist
Apartment Income REIT price target lowered to $45 from $49 at Truist
05/25/22 Truist
Apartment Income REIT price target lowered to $49 from $58 at Truist
05/19/22 Scotiabank
Apartment Income REIT price target lowered to $53 from $56 at Scotiabank
05/09/22 BTIG
Apartment Income REIT initiated with a Neutral at BTIG
AIRC Apartment Income REIT
$41.36 /

+0.02 (+0.05%)

05/02/22
Apartment Income REIT now sees FY FFO $2.37-$2.45, consensus $2.41
05/02/22
Apartment Income REIT reports Q1 FFO 57c, consensus 57c
Hot Stocks
Trump Media issues statement on Digital World Acquisition Corp. SEC filing » 07:55
06/27/22
06/27
07:55
06/27/22
07:55
DWAC

Digital World Acquisition

$27.81 /

-0.06 (-0.22%)

Trump Media &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

07:32 Today
Digital World Acquisition says Garelick to resign from board
07:31 Today
Trump-linked SPAC Digital World reports receipt of grand jury subpoena
06/15/22
Digital World Acquisition working toward consummating combination w/ Trump Media
06/13/22
Digital World Acquisition says SEC recently issued further subpoena
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

05/06/22
Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports
04/20/22
Digital World Acquisition named as short idea by Kerrisdale Capital
04/15/22
Fox News says didn't authorize account on Truth Social, Axios reports
04/12/22
Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

05/18/22
#SocialStocks: Musk and Twitter working to close $44B deal, despite noise
05/16/22
What You Missed On Wall Street On Monday
05/16/22
What You Missed On Wall Street This Morning
05/01/22
Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

06/24/22
Largest borrow rate increases among liquid names
06/17/22
Digital World Acquisition Corp put volume heavy and directionally bearish
06/15/22
Unusually active option classes on open June 15th
06/13/22
Digital World Acquisition Corp put volume heavy and directionally bearish
Recommendations
Amedisys' Contessa finalizing '9-figure revenue contract,' says Jefferies » 07:51
06/27/22
06/27
07:51
06/27/22
07:51
AMED

Amedisys

$115.40 /

+0.11 (+0.10%)

After having hosted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

06/24/22
Memorial Hermann, Contessa partner for new at-home care options
06/09/22
Amedisys releases inaugural ESG Report
06/09/22
Baylor Scott & White Health an Amedisy announce home care partnership
04/26/22
Amedisys promotes Muscato as Chief Strategy Officer
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

06/22/22 Benchmark
Benchmark doesn't expect proposed Medicare home health cut to make final rule
06/21/22 BofA
Amedisys cut to Underperform at BofA after CMS proposal on home health rates
06/21/22 BofA
Amedisys downgraded to Underperform from Neutral at BofA
06/21/22 Deutsche Bank
Amedisys price target lowered to $175 from $210 at Deutsche Bank
AMED Amedisys
$115.40 /

+0.11 (+0.10%)

04/27/22
Amedisys sees FY22 adjusted EPS $5.23-$5.45, consensus $5.33
04/27/22
Amedisys reports Q1 adjusted EPS $1.23, consensus $1.12
02/23/22
Amedisys sees FY22 EPS $5.23-$5.45, consensus $5.84
02/23/22
Amedisys reports Q4 EPS $1.18, consensus $1.18
Hot Stocks
Cronos Group announces partnership with Geocann » 07:49
06/27/22
06/27
07:49
06/27/22
07:49
CRON

Cronos Group

$3.11 /

+0.155 (+5.25%)

Cronos Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

06/21/22
Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone
06/21/22
Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone
03/21/22
Cronos Group founder Mike Gorenstein returns as CEO
03/01/22
Cronos Group announces planned exit of Peace Naturals Campus in Ontario
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

05/10/22
Cronos Group reports Q1 EPS (9c), consensus (8c)
03/01/22
Cronos Group reports 2021 EPS ($1.07), consensus (47c)
02/18/22
Cronos Group reports Q3 EPS 21c, consensus (10c)
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

04/11/22
NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says
04/01/22
U.S. House backs federal marijuana legalization bill, Marijuana Moment reports
03/24/22
House to vote on marijuana legalization bill next week, Marijuana Moment says
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

06/23/22
Here's What You Missed in Cannabis This Week
06/16/22
Here's What You Missed in Cannabis This Week
06/09/22
Rising High: Exclusive talk with cannabis testing firm Green Scientific
06/02/22
Here's What You Missed in Cannabis This Week
CRON Cronos Group
$3.11 /

+0.155 (+5.25%)

03/25/22
Unusually active option classes on open March 25th
Hot Stocks
Freyr announces Minister of Trade, Industry launched Norwegian battery strategy » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
FREY

Freyr Battery

$6.93 /

-0.005 (-0.07%)

FREYR Battery welcomes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

06/15/22
Freyr Battery concludes raw material pacts to supply battery materials
05/25/22
Freyr Battery signs heads of terms for renewable power with Statkraft
05/18/22
Freyr Battery signs agreement with Vaasa for lease of 130 hectares of land
05/16/22
David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

06/20/22 Goldman Sachs
Freyr Battery initiated with a Neutral at Goldman Sachs
03/17/22 US Capital Advisors
Freyr Battery initiated with a Buy at US Capital Advisors
01/26/22 Clarksons Platou
Freyr Battery initiated with a Buy at Clarksons Platou
01/04/22 Morgan Stanley
Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

05/11/22
Freyr Battery reports Q1 EPS (30c), consensus (14c)
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

06/15/22
Fly Intel: Pre-market Movers
01/19/22
Wall Street in Fives - Must Read Lists for Wednesday
01/19/22
Wall Street in Fives - Must Read Lists at Midday
FREY Freyr Battery
$6.93 /

-0.005 (-0.07%)

04/28/22
FREYR Battery call volume above normal and directionally bullish
Conference/Events
Relay Therapeutics to hold virtual event » 07:45
06/27/22
06/27
07:45
06/27/22
07:45
RLAY

Relay Therapeutics

$20.87 /

+1.87 (+9.84%)

Virtual Investor and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

01/27/22
Relay Therapeutics treatment of cholangiocarcinoma granted orphan designation
01/04/22
Relay first patient dosed in trial of RLY-2608, initiates RLY-4008 expansion
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

06/06/22 Jefferies
Relay Therapeutics initiated with an Underperform at Jefferies
05/10/22 H.C. Wainwright
Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright
05/09/22 JMP Securities
Relay Therapeutics price target lowered to $35 from $50 at JMP Securities
02/01/22 Berenberg
Relay Therapeutics initiated with a Buy at Berenberg
RLAY Relay Therapeutics
$20.87 /

+1.87 (+9.84%)

05/05/22
Relay Therapeutics reports Q1 EPS (57c), consensus (62c)
02/24/22
Relay Therapeutics reports Q4 EPS ($3.82), consensus (58c)
  • 13
    Oct
08:00 Today
Relay Therapeutics
Recommendations
Altria Group price target lowered to $45 from $56 at Cowen » 07:43
06/27/22
06/27
07:43
06/27/22
07:43
MO

Altria Group

$43.41 /

+0.905 (+2.13%)

Cowen analyst Vivien Azer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22
Juul to seek stay of FDA decision, exploring 'all options' under law
06/23/22
FDA denies authorization to market JUUL products
06/23/22
FDA denies authorization to market JUUL products
04/28/22
FDA proposes rules prohibiting menthol cigarettes and flavored cigars
MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22 Morgan Stanley
Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
06/22/22 Goldman Sachs
Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
06/22/22 Stifel
Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
06/22/22 Jefferies
FDA lowered nicotine rule likely to take many years to implement, says Jefferies
MO Altria Group
$43.41 /

+0.905 (+2.13%)

05/19/22
Altria Group backs FY22 adjusted EPS view $4.79-$4.93, consensus $4.86
04/28/22
Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84
04/28/22
Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18
04/27/22
Notable companies reporting before tomorrow's open
MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22
Appeals court halts FDA's ban on Juul e-cigarettes, AP reports
06/22/22
FDA to order Juul to take e-cigarettes off U.S. market, WSJ reports
06/21/22
Biden administration plans move to reduce nicotine in cigarettes, WaPo reports
MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/24/22
What You Missed On Wall Street On Friday
06/24/22
What You Missed On Wall Street This Morning
06/24/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
06/23/22
What You Missed On Wall Street On Thursday
07/28/22
Altria Group - MO
MO Altria Group
$43.41 /

+0.905 (+2.13%)

06/23/22
Unusually active option classes on open June 23rd
06/22/22
Altria Group put volume heavy and directionally bearish
06/22/22
Unusually active option classes on open June 22nd
05/10/22
Unusually active option classes on open May 10th
Recommendations
Rockwell Automation price target lowered to $260 from $277 at Morgan Stanley » 07:42
06/27/22
06/27
07:42
06/27/22
07:42
ROK

Rockwell Automation

$201.07 /

+3.735 (+1.89%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/23/22
HP Inc. names Ernest Nicolas as chief supply chain officer
05/03/22
Rockwell Automation CEO: It was a tough quarter, below our expectations
05/03/22
Rockwell Automation falls -13.9%
05/03/22
Rockwell Automation board authorizes additional $1B for share repurchases
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/24/22 Barclays
Rockwell Automation price target lowered to $200 from $220 at Barclays
05/10/22 HSBC
Rockwell Automation price target lowered to $240 from $293 at HSBC
05/05/22 JPMorgan
Rockwell Automation price target lowered to $200 from $220 at JPMorgan
05/04/22 Oppenheimer
Rockwell Automation price target lowered to $290 from $360 at Oppenheimer
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/03/22
Rockwell cuts FY22 revenue growth view to 11% - 15% from 16% - 19%
05/03/22
Rockwell Automation cuts FY22 EPS view to $9.20 - $9.80 from $10.50 - $11.10
05/03/22
Rockwell Automation reports Q2 EPS $1.66, consensus $2.26
05/02/22
Notable companies reporting before tomorrow's open
ROK Rockwell Automation
$201.07 /

+3.735 (+1.89%)

05/03/22
What You Missed On Wall Street On Tuesday
05/03/22
What You Missed On Wall Street This Morning
05/03/22
Fly Intel: Pre-market Movers
01/27/22
Wall Street in Fives - Must Read Lists for Thursday
Recommendations
Roche price target lowered to $48 from $58 at Cowen » 07:41
06/27/22
06/27
07:41
06/27/22
07:41
RHHBY

Roche

$41.64 /

+1.63 (+4.07%)

Cowen analyst Steve Scala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

06/16/22
FTC says to ramp up enforcement against illegal drug rebate schemes
06/16/22
Roche launches human papillomavirus self-sampling solution
06/16/22
Roche says crenezumab did not slow decline in autosomal dominant Alzheimer's
06/15/22
Roche announces FDA EUA for cobas SARS-CoV-2 Duo
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

06/02/22 Piper Sandler
Piper ups Repare Therapeutics target after 'great deal' with Roche
05/19/22 Credit Suisse
Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
05/12/22 Morgan Stanley
Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

04/25/22
Roche reports Q1 group sales CHF 16.445B vs. CHF 14.93B last year
02/03/22
Roche sees FY22 core earnings growing in low- to mid-single digit range
02/03/22
Roche reports 2021 core EPS CHF 19.81 vs CHF 19.16
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

02/24/22
Drugmakers criticize Medicare proposal on Biogen's Alzheimer's drug, WSJ says
02/09/22
Credit Suisse shareholders to block moves to extend Schwan's tenure, FT reports
RHHBY Roche
$41.64 /

+1.63 (+4.07%)

06/02/22
What You Missed On Wall Street This Morning
01/13/22
Meet Prothena: Fly exclusive interview with CEO Gene Kinney
07/21/22
Roche - RHHBY
Hot Stocks
Accenture to acquire XtremeEDA, terms not disclosed » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
ACN

Accenture

$299.36 /

+13.3 (+4.65%)

Accenture "has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/23/22
Johnson Controls, Accenture partner on OpenBlue Innovation Centers
06/23/22
Accenture raises FY22 negative FX impact view to 4.5% from 3%
06/23/22
Accenture sees FY22 operating cash flow $8.7B-$9.2B
06/06/22
Accenture acquires technology consultancy and managed services provider Advocate
ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/25/22 Barclays
Accenture price target lowered to $370 from $455 at Barclays
06/24/22 RBC Capital
Accenture price target lowered to $357 from $435 at RBC Capital
06/24/22 Cowen
Accenture price target lowered to $325 from $330 at Cowen
06/24/22 Baird
Accenture price target lowered to $310 from $340 at Baird
ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/23/22
Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B
06/23/22
Accenture narrows FY22 EPS view to $10.61-$10.70 from $10.61-$10.81
06/23/22
Accenture reports Q3 EPS $2.79, consensus $2.72
06/22/22
Notable companies reporting before tomorrow's open
ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/23/22
What You Missed On Wall Street On Thursday
06/23/22
What You Missed On Wall Street This Morning
06/23/22
Fly Intel: Pre-market Movers
03/17/22
What You Missed On Wall Street On Thursday
09/22/22
Accenture - ACN
ACN Accenture
$299.36 /

+13.3 (+4.65%)

06/10/22
Accenture call volume above normal and directionally bullish
04/20/22
Largest borrow rate increases among liquid names
Recommendations
Merck price target raised to $102 from $95 at Cowen » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
MRK

Merck

$93.22 /

+1.14 (+1.24%)

, SGEN

Seagen

$179.14 /

+5.07 (+2.91%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$93.22 /

+1.14 (+1.24%)

06:57 Today
AstraZeneca, Merck announce LYNPARZA receives positive opinion from CHMP
06:18 Today
AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer
06/24/22
European Commission approves KEYTRUDA as adjuvant treatment for melanoma
06/24/22
Merck: EC approves KEYTRUDA for treatment of stage IIB or IIC melanoma
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/17/22
Seattle Genetics trading resumes
06/17/22
Seagen jumps 10% to $161.79 after WSJ report of Merck interest
06/17/22
Seattle Genetics trading halted, volatility trading pause
06/06/22
Seagen, Genmab present data from tisotumab vedotin clinical development program
MRK Merck
$93.22 /

+1.14 (+1.24%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
04/12/22 Barclays
Merck price target raised to $97 from $94 at Barclays
04/11/22 H.C. Wainwright
Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/24/22 Mizuho
Merck deal would add 'novel and validated technology,' says Mizuho
06/23/22 BMO Capital
Seagen initiated with a Market Perform at BMO Capital
06/21/22 Morgan Stanley
Seagen named 'Catalyst Driven Idea' at Morgan Stanley
06/21/22 Oppenheimer
Seagen price target raised to $208 from $160 at Oppenheimer
MRK Merck
$93.22 /

+1.14 (+1.24%)

04/28/22
Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24
04/28/22
Merck reports Q1 adjusted EPS $2.14, consensus $1.83
04/27/22
Notable companies reporting before tomorrow's open
04/27/22
Notable companies reporting before tomorrow's open
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

04/28/22
Seagen sees FY22 total revenue $1.665B-$1.745B, consensus $1.78B
04/28/22
Seagen reports Q1 EPS (74c), consensus ($1.00)
02/10/22
Seagen sees FY22 total revenue $1.67B-$1.75B, consensus $2.16B
02/09/22
Seagen reports Q4 EPS (95c), consensus (83c)
MRK Merck
$93.22 /

+1.14 (+1.24%)

06/24/22
Merck moving forward with potential Seagen deal, WSJ reports
06/17/22
Merck, other suitors interested in acquiring Seagen, WSJ reports
06/17/22
Merck considering acquisition of Seagen, WSJ reports
05/31/22
Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/24/22
Merck moving forward with potential Seagen deal, WSJ reports
06/17/22
Merck, other suitors interested in acquiring Seagen, WSJ reports
06/17/22
Merck considering acquisition of Seagen, WSJ reports
MRK Merck
$93.22 /

+1.14 (+1.24%)

06/24/22
What You Missed On Wall Street On Friday
06/24/22
What You Missed On Wall Street This Morning
06/24/22
Fly Intel: Pre-market Movers
06/17/22
What You Missed On Wall Street On Friday
SGEN Seagen
$179.14 /

+5.07 (+2.91%)

06/24/22
What You Missed On Wall Street On Friday
06/24/22
What You Missed On Wall Street This Morning
06/24/22
Fly Intel: Pre-market Movers
06/17/22
What You Missed On Wall Street On Friday
07/28/22
Merck - MRK
07/01/22
Extended PDUFA Date for Vaxneuvance
01/29/23
PDUFA Date for new sBLA for KEYTRUDA
10/04/22
Merck
MRK Merck
$93.22 /

+1.14 (+1.24%)

06/01/22
Merck put volume heavy and directionally bearish
05/31/22
Merck put volume heavy and directionally bearish
05/18/22
Merck put volume heavy and directionally bearish
04/04/22
Merck call buyer realizes 64% same-day gains
Hot Stocks
Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39
06/27/22
06/27
07:39
06/27/22
07:39
DVAX

Dynavax

$12.34 /

+0.07 (+0.57%)

China's Clover…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

05/17/22
Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17
05/12/22
Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17
02/28/22
Dynavax sees FY22 CpG 1018 adjuvant net product revenues of $550M
12/28/21
Dynavax notes Biological E's CORBEVAX received DCGI emergency use approval
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

01/05/22 Goldman Sachs
Goldman reinstates Dynavax at Buy, sees value creation from COVID platform
12/29/21 H.C. Wainwright
Dynavax price target raised to $28 from $23 at H.C. Wainwright
08/31/21 H.C. Wainwright
Dynavax price target raised to $23 from $20 at H.C. Wainwright
08/05/21 Goldman Sachs
Dynavax initiated with a Buy at Goldman Sachs
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

05/05/22
Dynavax still sees 2022 CpG 1018 adjuvant revenues at least $550M
05/05/22
Dynavax reports Q1 EPS 26c, consensus 24c
02/28/22
Dynavax reports Q4 EPS 55c, consensus 64c
DVAX Dynavax
$12.34 /

+0.07 (+0.57%)

05/12/22
Fly Intel: After-Hours Movers
Hot Stocks
TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TGTX

TG Therapeutics

$4.39 /

-0.235 (-5.08%)

TG Therapeutics …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

06/03/22
TG Therapeutics announces data presentations from ULTIMATE I, II Phase 3 trials
05/31/22
TG Therapeutics announces FDA extension of BLA PDUFA date for ublituximab
04/15/22
TG Therapeutics withdraws leukemia application, pulls Ukoniq from sale
04/06/22
TG Therapeutics announces presentation of ULTIMATE I & II Phase 3 trial data
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

06/13/22 B. Riley
TG Therapeutics price target lowered to $17 from $23 at B. Riley
05/20/22 BofA
BofA starts TG Therapeutics at Underperform, sees difficult commercial setup
05/20/22 BofA
TG Therapeutics initiated with an Underperform at BofA
04/19/22 B. Riley
TG Therapeutics application withdrawal 'clearing event,' says B. Riley
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

03/01/22
TG Therapeutics reports Q4 EPS (70c), consensus (63c)
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

04/18/22
What You Missed On Wall Street On Monday
04/18/22
What You Missed On Wall Street This Morning
01/27/22
Wall Street in Fives - Must Read Lists for Thursday
01/27/22
Wall Street in Fives - Must Read Lists at Midday
TGTX TG Therapeutics
$4.39 /

-0.235 (-5.08%)

06/09/22
Unusually active option classes on open June 9th
04/29/22
TG Therapeutics call volume above normal and directionally bullish
Recommendations
Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
TV

Televisa

$8.71 /

+0.34 (+4.06%)

JPMorgan analyst Marcelo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TV Televisa
$8.71 /

+0.34 (+4.06%)

06/01/22 Goldman Sachs
Televisa reinstated with a Neutral at Goldman Sachs
03/23/22 Barclays
Televisa upgraded to Equal Weight from Underweight at Barclays
03/18/22 JPMorgan
America Movil downgraded to Neutral from Overweight at JPMorgan
03/18/22 JPMorgan
Televisa resumed with Overweight from Neutral at JPMorgan
TV Televisa
$8.71 /

+0.34 (+4.06%)

03/23/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations
Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38
06/27/22
06/27
07:38
06/27/22
07:38
CPA

Copa Holdings

$63.84 /

+2.61 (+4.26%)

JPMorgan analyst Fernando…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

06/10/22
Copa Holdings reports preliminary May traffic down 4.2%, capacity down 3.7%
05/10/22
Copa Holdings reports preliminary April traffic statistics
04/13/22
Copa Holdings reports preliminary March traffic statistics
03/10/22
Copa Holdings reports preliminary February traffic down 13% vs. 2019
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

05/13/22 Barclays
Barclays double upgrades Copa Holdings on improving operations
05/13/22 Barclays
Copa Holdings upgraded to Overweight from Underweight at Barclays
04/13/22 Raymond James
Copa Holdings price target lowered to $110 from $115 at Raymond James
02/23/22 Barclays
Copa Holdings price target raised to $96 from $82 at Barclays
CPA Copa Holdings
$63.84 /

+2.61 (+4.26%)

05/11/22
Copa Holdings reports Q1 EPS 47c, consensus 29c
02/09/22
Copa Holdings reports Q4 EPS ex-items $1.98, consensus 89c
Hot Stocks
DocGo to be added to Russell 2000 Index » 07:37
06/27/22
06/27
07:37
06/27/22
07:37
DCGO

DocGo

$7.11 /

-0.39 (-5.20%)

DocGo announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

05/24/22
DocGo announces $40M share repurchase plan
05/17/22
DocGo expands mobile health services with Carnival
04/26/22
DocGo, Jefferson Health partner for patient transport
03/30/22
DocGo unit Ambulnz Community Partners awarded three 'sizeable' contracts
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

05/11/22 Canaccord
DocGo price target lowered to $10 from $13 at Canaccord
04/19/22 Deutsche Bank
DocGo initiated with a Buy at Deutsche Bank
01/19/22 Stifel
DocGo initiated with a Buy at Stifel
01/04/22 Northland
DocGo named a top pick for 2022 at Northland
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

05/09/22
DocGo backs FY22 revenue view $400M-$420M, consensus $410.59M
05/09/22
DocGo reports Q1 EPS 9c, consensus 4c
03/14/22
DocGo sees FY22 revenue $400M-$420M, consensus $385.2M
03/14/22
DocGo reports Q4 net income $20.3M vs. ($4.4M) last year
DCGO DocGo
$7.11 /

-0.39 (-5.20%)

01/11/22
Nine new option listings on January 11th
Hot Stocks
BridgeBio announces data for for BBP-711 to treat recurrent kidney stone formers » 07:35
06/27/22
06/27
07:35
06/27/22
07:35
BBIO

BridgeBio

$9.24 /

+0.175 (+1.93%)

BridgeBio Pharma …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

06/22/22
BridgeBio announces early data for BBP-812
06/17/22
Atai Life Sciences says Stephen Bardin to be named CFO in Q3
06/13/22
BridgeBio shares data from Phase 2b trial of encaleret
06/10/22
BridgeBio affiliate Venthera presents preliminary results from VT30 trial
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

03/16/22 H.C. Wainwright
BridgeBio price target lowered to $22 from $24 at H.C. Wainwright
03/11/22 JPMorgan
BridgeBio price target lowered to $18 from $21 at JPMorgan
01/03/22 Piper Sandler
Alnylam upgraded to Overweight from Neutral at Piper Sandler
12/30/21 BofA
Alnylam remains top pick for 2022 at Bofa amid recent volatility
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

05/05/22
BridgeBio reports Q1 EPS ($1.35), consensus ($1.11)
02/24/22
BridgeBio reports Q4 EPS ($1.01), consensus (87c)
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

05/12/22
Fly Intel: Pre-market Movers
12/27/21
Wall Street in Fives - Must Read Lists for Monday
12/27/21
Wall Street in Fives - Must Read Lists at Midday
12/27/21
Fly Intel: Pre-market Movers
BBIO BridgeBio
$9.24 /

+0.175 (+1.93%)

01/03/22
Unusually active option classes on open January 3rd
12/28/21
Unusually active option classes on open December 28th
Downgrade
Morgan Stanley downgrades Varonis to Equal Weight on slowing topline growth » 07:35
06/27/22
06/27
07:35
06/27/22
07:35
VRNS

Varonis

$34.92 /

+2.04 (+6.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

06/15/22
Varonis announces new features for cloud security offering
05/25/22
Varonis achieves Cloud Security Alliance STAR Certfication
04/26/22
Varonis announces features for securing sensitive data in Salesforce
01/25/22
Varonis announces Version 8.6 of the Varonis Data Security Platform
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

05:34 Today Morgan Stanley
Varonis downgraded to Equal Weight from Overweight at Morgan Stanley
05/23/22 Jefferies
Varonis price target lowered to $40 from $65 at Jefferies
05/10/22 Truist
Varonis price target lowered to $50 from $65 at Truist
05/03/22 Wedbush
Varonis price target lowered to $52 from $60 at Wedbush
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

05/02/22
Notable companies reporting after market close
02/07/22
Varonis sees FY22 EPS 16c-17c, consensus 22c
02/07/22
Varonis sees Q1 EPS (11c)-(10c), consensus (6c)
02/07/22
Varonis reports Q4 EPS 16c, consensus 13c
VRNS Varonis
$34.92 /

+2.04 (+6.20%)

05/02/22
Fly Intel: After-Hours Movers
04/26/22
What Wall Street is saying about Alphabet ahead of earnings
Earnings
Stealth Biotherapeutics announces receipt of preliminary non-binding proposal » 07:34
06/27/22
06/27
07:34
06/27/22
07:34
MITO

Stealth Biotherapeutics

/

+

Stealth BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

07:28 Today
Stealth BioTherapeutics Corporation (ADS) trading halted, news pending
06/14/22
Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide
06/08/22
Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study
05/31/22
Stealth granted orphan drug designation for elamipretide by EMA
MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
07/01/21 Maxim
Stealth Biotherapeutics initiated with a Buy at Maxim
Hot Stocks
Foot Locker to divest team sales business » 07:33
06/27/22
06/27
07:33
06/27/22
07:33
FL

Foot Locker

$29.56 /

+0.53 (+1.83%)

Foot Locker announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

07:32 Today
Foot Locker to divest team sales business
06/01/22
Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer
05/20/22
Foot Locker rises 9.5%
05/20/22
Foot Locker sees FY22 comparable sales down 8%-10%
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/24/22 Williams Trading
Foot Locker downgraded to Sell from Hold at Williams Trading
05/23/22 B. Riley
Foot Locker price target lowered to $33 from $34 at B. Riley
05/23/22 Deutsche Bank
Foot Locker price target raised to $32 from $30 at Deutsche Bank
05/23/22 Baird
Foot Locker price target raised to $32 from $30
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41
05/20/22
Foot Locker reports Q1 EPS $1.60, consensus $1.55
05/19/22
Notable companies reporting before tomorrow's open
05/19/22
Notable companies reporting before tomorrow's open
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

03/05/22
Foot Locker has gotten hit hard, stock looks like a buy, Barron's says
03/02/22
Fanatics valued at $27B in latest fundraising, WSJ reports
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
What You Missed On Wall Street On Friday
05/20/22
What You Missed On Wall Street This Morning
05/20/22
Fly Intel: Pre-market Movers
03/28/22
What You Missed On Wall Street On Monday
08/19/22
Foot Locker - FL
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
Unusually active option classes on open May 20th
04/20/22
Foot Locker call volume above normal and directionally bullish
03/04/22
Foot Locker put volume heavy and directionally bearish
02/23/22
Unusually active option classes on open February 23rd
Hot Stocks
Holley added to membership of the small-cap Russell 2000 Index » 07:33
06/27/22
06/27
07:33
06/27/22
07:33
HLLY

Holley

$10.21 /

+0.21 (+2.10%)

Holley was added as a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLLY Holley
$10.21 /

+0.21 (+2.10%)

04/20/22
Holley falls -9.9%
04/20/22
Holley falls -9.2%
04/20/22
Holley falls -8.0%
01/10/22
Holley completes acquisition of brands during Q4 for approximately $56M
HLLY Holley
$10.21 /

+0.21 (+2.10%)

06/22/22 BofA
Holley initiated with a Buy at BofA
03/04/22 Jefferies
Holley assumed with a Buy rating, $20 price target at Jefferies
09/09/21 Truist
Truist starts Holley at Buy with positive view of secular growth attributes
09/09/21 Truist
Holley initiated with a Buy at Truist
HLLY Holley
$10.21 /

+0.21 (+2.10%)

05/12/22
Holley reports Q1 EPS 18c, consensus 15c
04/19/22
Holley sees Q1 revenue $199M-$200M, consensus $180.6M
03/03/22
Holley sees FY22 revenue $765-$790M, consensus $718.69M
03/03/22
Holley reports Q4 EPS 8c consensus 12c
  • 21
    Apr
HLLY Holley
$10.21 /

+0.21 (+2.10%)

06/22/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
04/19/22
Fly Intel: After-Hours Movers
03/04/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks
Digital World Acquisition says Garelick to resign from board » 07:32
06/27/22
06/27
07:32
06/27/22
07:32
DWAC

Digital World Acquisition

$27.81 /

-0.06 (-0.22%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

07:31 Today
Trump-linked SPAC Digital World reports receipt of grand jury subpoena
06/15/22
Digital World Acquisition working toward consummating combination w/ Trump Media
06/13/22
Digital World Acquisition says SEC recently issued further subpoena
05/18/22
Trump Media & Technology Group launches Truth Social Web App
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

05/06/22
Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports
04/20/22
Digital World Acquisition named as short idea by Kerrisdale Capital
04/15/22
Fox News says didn't authorize account on Truth Social, Axios reports
04/12/22
Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

05/18/22
#SocialStocks: Musk and Twitter working to close $44B deal, despite noise
05/16/22
What You Missed On Wall Street On Monday
05/16/22
What You Missed On Wall Street This Morning
05/01/22
Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter
DWAC Digital World Acquisition
$27.81 /

-0.06 (-0.22%)

06/24/22
Largest borrow rate increases among liquid names
06/17/22
Digital World Acquisition Corp put volume heavy and directionally bearish
06/15/22
Unusually active option classes on open June 15th
06/13/22
Digital World Acquisition Corp put volume heavy and directionally bearish
Hot Stocks
Foot Locker to divest team sales business  07:32
06/27/22
06/27
07:32
06/27/22
07:32
FL

Foot Locker

$29.56 /

+0.53 (+1.83%)

 
ShowHide Related Items >><<
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

06/01/22
Foot Locker appoints Neil Bansal as Chief Strategy & Transformation Officer
05/20/22
Foot Locker rises 9.5%
05/20/22
Foot Locker sees FY22 comparable sales down 8%-10%
05/05/22
Foot Locker, Adidas announce new long-term strategic partnership
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/24/22 Williams Trading
Foot Locker downgraded to Sell from Hold at Williams Trading
05/23/22 B. Riley
Foot Locker price target lowered to $33 from $34 at B. Riley
05/23/22 Deutsche Bank
Foot Locker price target raised to $32 from $30 at Deutsche Bank
05/23/22 Baird
Foot Locker price target raised to $32 from $30
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41
05/20/22
Foot Locker reports Q1 EPS $1.60, consensus $1.55
05/19/22
Notable companies reporting before tomorrow's open
05/19/22
Notable companies reporting before tomorrow's open
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

03/05/22
Foot Locker has gotten hit hard, stock looks like a buy, Barron's says
03/02/22
Fanatics valued at $27B in latest fundraising, WSJ reports
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
What You Missed On Wall Street On Friday
05/20/22
What You Missed On Wall Street This Morning
05/20/22
Fly Intel: Pre-market Movers
03/28/22
What You Missed On Wall Street On Monday
08/19/22
Foot Locker - FL
FL Foot Locker
$29.56 /

+0.53 (+1.83%)

05/20/22
Unusually active option classes on open May 20th
04/20/22
Foot Locker call volume above normal and directionally bullish
03/04/22
Foot Locker put volume heavy and directionally bearish
02/23/22
Unusually active option classes on open February 23rd
Hot Stocks
Aptose Biosciences appoints Fletcher Payne as SVP, CFO » 07:32
06/27/22
06/27
07:32
06/27/22
07:32
APTO

Aptose Biosciences

/

+

Aptose Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
/

+

06/02/22
Aptose Biosciences presents highlights from corporate update, KOL event
05/04/22
Aptose Biosciences receives Fast Track designation for HM43239
04/13/22
iKena Oncology appoints Marango as CFO, Head of Corporate Development
04/07/22
Aptose Biosciences appoints Ledru as CCO, Marango to resign as CFO, CBO
APTO Aptose Biosciences
/

+

04/28/22 Cantor Fitzgerald
Aptose Biosciences assumed with an Overweight at Cantor Fitzgerald
12/20/21 Piper Sandler
Aptose Biosciences price target lowered to $3 from $7 at Piper Sandler
12/20/21 H.C. Wainwright
Aptose price target lowered to $12 from $14 at H.C. Wainwright
12/14/21 Alliance Global Partners
Aptose price target lowered to $8 from $12 at Alliance Global Partners
APTO Aptose Biosciences
/

+

05/09/22
Aptose Biosciences reports Q1 EPS (12c), consensus (15c)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.